The change of cytokines in tear fluid with dry eye patients after rebamipide instillation

Trial Profile

The change of cytokines in tear fluid with dry eye patients after rebamipide instillation

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Jul 2017

At a glance

  • Drugs Rebamipide (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2017 Status changed from recruiting to completed.
    • 26 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top